Understanding Patient-Derived Glioblastoma Multiforme Cells’ Proliferation
Glioblastoma multiforme (GBM) is the most common and aggressive type of primary brain tumor. Patients with GBM have a median survival of 15 months. Thus, treating GBM can be achieved by inhibiting the proliferation of the patient-derived cells using leaf extract of B. monnieri.